Goal-directed perfusion to reduce acute kidney injury: A randomized trial

Area of Science:

• Cardiology
• Nephrology
• Surgical Critical Care

Background:

• Acute kidney injury (AKI) is a significant complication following cardiac surgery.
• Maintaining adequate oxygen delivery (DO2) during cardiopulmonary bypass (CPB) is crucial for organ protection.
• Current perfusion strategies may not consistently optimize DO2, potentially contributing to AKI.

Purpose of the Study:

• To evaluate the efficacy of a goal-directed perfusion (GDP) strategy in reducing the incidence of AKI after cardiac surgery.
• To compare GDP with conventional perfusion management during CPB.
• To assess the impact of GDP on AKI severity and secondary clinical outcomes.

Main Methods:

• A multicenter randomized trial involving 350 patients undergoing cardiac surgery.
• Patients were assigned to either a GDP strategy (maintaining DO2 ≥280 mL·min⁻¹·m⁻²) or conventional perfusion.
• The primary endpoint was the rate of AKI, with secondary endpoints including ICU length of stay, morbidity, and mortality.

Main Results:

• GDP significantly reduced the incidence of AKIN stage 1 AKI (RR, 0.45; P=.01).
• No significant difference in AKIN stage 2-3 AKI was observed between groups (RR, 1.66; P=.528).
• In patients with CPB duration of 1-3 hours, GDP showed a more pronounced reduction in AKI (RR, 0.49; P=.017).

Conclusions:

• A goal-directed perfusion strategy is effective in preventing early-stage AKI (AKIN stage 1) in cardiac surgery.
• Further research is needed to identify perfusion interventions that can mitigate more severe forms of renal injury (AKIN stage 2-3).
• GDP may be particularly beneficial for patients with moderate CPB times.